Osteoporosis is the second most common disease only secondary to cardiovascular
disease, with the risk of fracture increasing with age. Osteoporosis is caused by an …

Postmenopausal osteoporosis (PMOP) is a systemic chronic bone metabolic disease
caused by the imbalance between bone formation and bone resorption mediated by …

We fabricated graphene oxide (GO)-incorporated polylactic acid (PLA)(GO-PLA) films by
using three-dimensional (3D) printing to explore their potential benefits as barrier …

Abstract The effects of Liuwei Dihuang pill (LWDH) on diabetic nephropathy-related
osteoporosis (DNOP) are unclear. The present study aimed to evaluate the effects of LWDH …

Melon is of great value in food, medicine and industry. In recent years, the continuous
cropping obstacles of melon is increasingly prominent, which seriously affects the …

Bone mass loss occurs with a decrease in osteoblast proliferation and differentiation, or the
enhancement of bone resorption, which further leads to the impairment of bone mineral …

Polyphenols are widely known for their antioxidant activity, ie, they have the ability to
suppress oxidative stress, and this behavior is mediated by the autoxidation of their phenolic …

Purpose Accumulating evidence has shown that serum uric acid (UA) is associated with
some chronic diseases owing to its antioxidant capacity; however, previous research has …

Osteoporosis is a bone-debilitating disease, demonstrating a higher prevalence in post-
menopausal women due to estrogen deprivation. One of the main mechanisms underlying …

Current osteoporosis medications have drawbacks of causing side effects and having slow
onset, therefore developing osteoporosis drugs with faster onset and less side effects is …